Quinoxalinone as a Privileged Platform in Drug Development

Title:Quinoxalinone as a Privileged Platform in Drug Development

Volume: 18 Issue: 5

Author(s): Leilei Shi, Wei Hu, Jifeng Wu, Huaiyu Zhou, Hua Zhou and Xun Li*

Affiliation:

• Key Laboratory of Chemistry and Chemical Biology (Ministry of Education), Department of Pharmaceutical Science, College of Pharmacy, Shandong University, Jinan,China

Keywords: Binding mode, biological activities, derivates, quinoxaline, quinoxalinone skeleton, SAR analysis.

Abstract: Among the family of nitrogen-containing heterocycles, quinoxalinone (or quinoxalin-2-one) core, characterized by pyrazin-2(1H)-one fused to benzene ring at two adjacent carbon atoms, has been frequently found in a variety of pharmacologically active compounds with biological or pharmaceutical applications. It was gratifying that a larger part of these bioactive quinoxalinone-based derivatives has entered various clinical trials, which in turn hastens the synthetic versatility and also initiates various derivatization of quinoxalinone scaffold. In this review, we highlighted the newly emerged quinoxalinone- based derivatives or analogues, with the emphasis of their biological applications and structure-activity analysis covering literatures in recent years.

Cite this article as:

Shi Leilei, Hu Wei , Wu Jifeng , Zhou Huaiyu, Zhou Hua and Li Xun*, Quinoxalinone as a Privileged Platform in Drug Development, Mini-Reviews in Medicinal Chemistry 2018; 18 (5) . https://dx.doi.org/10.2174/1389557517666171101111134